This site is intended for health professionals only

Published on 23 November 2011

Share this story:
Twitter
LinkedIn
RELATED ARTICLES
J&J announce filings to FDA for schizophrenia drug
Twice-daily INCIVO® in genotype-1 chronic hepatitis C virus
Micafungin in the treatment of fungal infection
European Commission approves INOMAX® cardiac surgery
GSK, Novartis, LEO and Lilly Boards join forces to set new patient-pharma standard

Understanding compassionate-use programmes

teaser

 

Prof Paola Minghetti, PhD  

Professor of Pharmaceutical Sciences, Universit



Most read

1
User-friendly osteoporosis therapy launched
2
Helapet introduce new, improved 20mm Vented Vial Adapter
3
Merck agrees huge Vioxx settlement
4
Janssen-Cilag’s Stelara approved by NICE
5
Issues affecting access to orphan drugs in Europe



Latest Issue

Read the latest issue >
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
Share this story:
Twitter
LinkedIn
RELATED ARTICLES
B Braun announces sixth workshop on injection safety
Thousands killed by drug reactions
Quality assurance framework for pharmacy education launched
UCB Receives Complete Response Letter from FDA
Developments in photodynamic therapy